Malignant solid tumors or Cancer of unknown primary Malignant solid tumors, Comprehensive cancer genome profiling, QOL
Conditions
Interventions
None listed
Sponsors
Koyama Takafumi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients 1) Patients at National Cancer Center Hospital 2) Pathologically diagnosed as malignant solid tumor 3) Planned to perform comprehensive cancer genome profiling 4) With written informed consent Family member of Patients 1) Family member of Patients consented to this trial 2) Family member of Patients who also attend the appointment for result of comprehensive cancer genome profiling 3) Family member of Patients with written informed consent
Exclusion criteria
Exclusion criteria: Patients 1) Patients with difficulty writing and reading Japanese 2) Others judged by the investigator to be unsuitable for the study Family member of Patients 1) Family member of Patients difficulty writing and reading Japanese 2) Family member of Patients who was others judged by the investigator to be unsuitable for the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of depression at before comprehensive cancer genome profiling test, at the time of explanation of the result, at three times after the test, at the six months after the test | — |
Secondary
| Measure | Time frame |
|---|---|
| Anxiety, QOL, Symptom, Satisfaction, Quality of communication, Knowledge of comprehensive cancer genome profiling test, Social support, Medical backgorund, Social background, Medical information at before comprehensive cancer genome profiling test, at the time of explanation of the result, at three times after the test, at the six months after the test | — |
Contacts
Public ContactMakoto Nishino
National Cancer Center Hospital
Outcome results
None listed